Dr. Lasika Seneviratne
Claim this profileLos Angeles Hematology Oncology Medical Group
Area of expertise
Multiple Myeloma
Lasika Seneviratne has run 3 trials for Multiple Myeloma.
Lung Cancer
Lasika Seneviratne has run 3 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Los Angeles Hematology Oncology Medical Group
Los Angeles Cancer Network
Clinical Trials Lasika Seneviratne is currently running
Mezigdomide + Carfilzomib + Dexamethasone
for Multiple Myeloma
This trial is testing a new drug called Mezigdomide combined with two other drugs to treat patients whose blood cancer has come back or not responded to previous treatments. The new drug aims to stop cancer cells from growing and spreading.
Recruiting
2 awards
Phase 3
AVM0703
for Lymphoma
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) infusion to patients with lymphoid malignancies.
Recruiting
1 award
Phase 1 & 2
6 criteria
More about Lasika Seneviratne
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Lasika Seneviratne has experience with
- Dexamethasone
- Pembrolizumab
- AVM0703
- Supra-Pharmacologic Dexamethasone Sodium Phosphate
- Trilaciclib
- Sacituzumab Govitecan-hziy
Breakdown of trials Lasika Seneviratne has run
Multiple Myeloma
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lasika Seneviratne specialize in?
Lasika Seneviratne focuses on Multiple Myeloma and Lung Cancer. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Lasika Seneviratne currently recruiting for clinical trials?
Yes, Lasika Seneviratne is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Lasika Seneviratne has studied deeply?
Yes, Lasika Seneviratne has studied treatments such as Dexamethasone, Pembrolizumab, AVM0703.
What is the best way to schedule an appointment with Lasika Seneviratne?
Apply for one of the trials that Lasika Seneviratne is conducting.
What is the office address of Lasika Seneviratne?
The office of Lasika Seneviratne is located at: Los Angeles Hematology Oncology Medical Group, Los Angeles, California 90017 United States. This is the address for their practice at the Los Angeles Hematology Oncology Medical Group.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.